Neuraxis, Inc. (NRXS) - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Neuraxis, Inc., a Delaware corporation, on May 28, 2025, reporting events occurring on May 23, 2025. The Company is an emerging growth company with its principal executive offices in Carmel, Indiana. Its common stock trades on the NYSE American under the symbol "NRXS."
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves as a disclosure notice rather than a financial statement.
Material Changes
No material financial changes or operational events are detailed within the text of this filing. The primary event is the public release of an investor presentation.
Guidance, Outlook, and Management Commentary
- Investor Presentation: On May 23, 2025, the Company posted an Investor Presentation to its website (https://ir.neuraxis.com/) covering strategy, performance, and future objectives.
- Forward-Looking Statements: The filing incorporates by reference the "Forward-Looking Statements" disclosure contained within the Investor Presentation.
- Liability Disclaimer: The information in Item 7.01 is not deemed "filed" under Section 18 of the Exchange Act and is not incorporated by reference into other registration statements unless expressly stated.
Investor Verification Checklist
- Review the full "Neuraxis, Inc. Investor Presentation (May 2025)" (Exhibit 99.1) for specific financial data and strategic details.
- Verify the "Forward-Looking Statements" section within the presentation to understand the risks and assumptions behind management's outlook.
- Confirm the Company's status as an emerging growth company and any associated reporting exemptions.